{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:00:48Z","timestamp":1768438848005,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T00:00:00Z","timestamp":1333584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T00:00:00Z","timestamp":1333584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1038\/leu.2012.99","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T06:37:51Z","timestamp":1333607871000},"page":"2277-2285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["E2F4 plays a key role in Burkitt lymphoma tumorigenesis"],"prefix":"10.1038","volume":"26","author":[{"given":"I","family":"Molina-Privado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Jim\u00e9nez-P","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Montes-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Chiodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rodr\u00edguez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"S\u00e1nchez-Verde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"Piris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M R","family":"Campanero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,5]]},"reference":[{"key":"BFleu201299_CR1","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2008","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW . Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008."},{"key":"BFleu201299_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0165-5876(86)80060-X","volume":"12","author":"DB Kearns","year":"1986","unstructured":"Kearns DB, Smith RJ, Pitcock JK . Burkitt\u2019s lymphoma. Int J Pediatr Otorhinolaryngol 1986; 12: 73\u201384.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"BFleu201299_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/MOH.0b013e3281bccdee","volume":"14","author":"JT Yustein","year":"2007","unstructured":"Yustein JT, Dang CV . Biology and treatment of Burkitt\u2019s lymphoma. Curr Opin Hematol 2007; 14: 375\u2013381.","journal-title":"Curr Opin Hematol"},{"key":"BFleu201299_CR4","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","volume":"109","author":"C Patte","year":"2007","unstructured":"Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R et al. Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 2007; 109: 2773\u20132780.","journal-title":"Blood"},{"key":"BFleu201299_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.semcancer.2009.07.001","volume":"19","author":"G Klein","year":"2009","unstructured":"Klein G . Burkitt lymphoma\u2014a stalking horse for cancer research? Semin Cancer Biol 2009; 19: 347\u2013350.","journal-title":"Semin Cancer Biol"},{"key":"BFleu201299_CR6","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.1038\/sj.onc.1206815","volume":"22","author":"C Bellan","year":"2003","unstructured":"Bellan C, De Falco G, Lazzi S, Leoncini L . Pathologic aspects of AIDS malignancies. Oncogene 2003; 22: 6639\u20136645.","journal-title":"Oncogene"},{"key":"BFleu201299_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ijc.2910450332","volume":"45","author":"NA Hotchin","year":"1990","unstructured":"Hotchin NA, Allday MJ, Crawford DH . Deregulated c-myc expression in Epstein-Barr-virus-immortalized B-cells induces altered growth properties and surface phenotype but not tumorigenicity. Int J Cancer 1990; 45: 566\u2013571.","journal-title":"Int J Cancer"},{"key":"BFleu201299_CR8","first-page":"11","volume":"1242","author":"G Packham","year":"1995","unstructured":"Packham G, Cleveland JL . c-Myc and apoptosis. Biochim Biophys Acta 1995; 1242: 11\u201328.","journal-title":"Biochim Biophys Acta"},{"key":"BFleu201299_CR9","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1073\/pnas.190327097","volume":"97","author":"DW Felsher","year":"2000","unstructured":"Felsher DW, Zetterberg A, Zhu J, Tlsty T, Bishop JM . Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl Acad Sci USA 2000; 97: 10544\u201310548.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201299_CR10","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1158\/0008-5472.CAN-08-4617","volume":"69","author":"I Molina-Privado","year":"2009","unstructured":"Molina-Privado I, Rodriguez-Martinez M, Rebollo P, Martin-Perez D, Artiga MJ, Menarguez J et al. E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma. Cancer Res 2009; 69: 4052\u20134058.","journal-title":"Cancer Res"},{"key":"BFleu201299_CR11","first-page":"131","volume":"1602","author":"J DeGregori","year":"2002","unstructured":"DeGregori J . The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta 2002; 1602: 131\u2013150.","journal-title":"Biochim Biophys Acta"},{"key":"BFleu201299_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2741\/A291","volume":"3","author":"DG Johnson","year":"1998","unstructured":"Johnson DG, Schneider-Broussard R . Role of E2F in cell cycle control and cancer. Front Biosci 1998; 3: 447\u2013458.","journal-title":"Front Biosci"},{"key":"BFleu201299_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nrc2696","volume":"9","author":"HZ Chen","year":"2009","unstructured":"Chen HZ, Tsai SY, Leone G . Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009; 9: 785\u2013797.","journal-title":"Nat Rev Cancer"},{"key":"BFleu201299_CR14","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1038\/sj.onc.1208619","volume":"24","author":"D Cobrinik","year":"2005","unstructured":"Cobrinik D . Pocket proteins and cell cycle control. Oncogene 2005; 24: 2796\u20132809.","journal-title":"Oncogene"},{"key":"BFleu201299_CR15","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1073\/pnas.90.15.6914","volume":"90","author":"EK Flemington","year":"1993","unstructured":"Flemington EK, Speck SH, Kaelin WG . E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 1993; 90: 6914\u20136918.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201299_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ceb.2007.10.003","volume":"19","author":"A Blais","year":"2007","unstructured":"Blais A, Dynlacht BD . E2F-associated chromatin modifiers and cell cycle control. Curr Opin Cell Biol 2007; 19: 658\u2013662.","journal-title":"Curr Opin Cell Biol"},{"key":"BFleu201299_CR17","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/MCB.16.4.1436","volume":"16","author":"K Moberg","year":"1996","unstructured":"Moberg K, Starz MA, Lees JA . E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 1996; 16: 1436\u20131449.","journal-title":"Mol Cell Biol"},{"key":"BFleu201299_CR18","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1128\/MCB.17.10.5771","volume":"17","author":"ES Knudsen","year":"1997","unstructured":"Knudsen ES, Wang JY . Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol Cell Biol 1997; 17: 5771\u20135783.","journal-title":"Mol Cell Biol"},{"key":"BFleu201299_CR19","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1073\/pnas.93.10.4633","volume":"93","author":"ZX Xiao","year":"1996","unstructured":"Xiao ZX, Ginsberg D, Ewen M, Livingston DM . Regulation of the retinoblastoma protein-related protein p107 by G1 cyclin-associated kinases. Proc Natl Acad Sci USA 1996; 93: 4633\u20134637.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201299_CR20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1101\/gad.14.7.804","volume":"14","author":"Y Takahashi","year":"2000","unstructured":"Takahashi Y, Rayman JB, Dynlacht BD . Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 2000; 14: 804\u2013816.","journal-title":"Genes Dev"},{"key":"BFleu201299_CR21","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.1128\/MCB.17.12.7268","volume":"17","author":"R Verona","year":"1997","unstructured":"Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA . E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 1997; 17: 7268\u20137282..","journal-title":"Mol Cell Biol"},{"key":"BFleu201299_CR22","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW . Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001."},{"key":"BFleu201299_CR23","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1073\/pnas.94.6.2221","volume":"94","author":"MR Campanero","year":"1997","unstructured":"Campanero MR, Flemington EK . Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci USA 1997; 94: 2221\u20132226.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201299_CR24","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1128\/MCB.14.10.6607","volume":"14","author":"E Neuman","year":"1994","unstructured":"Neuman E, Flemington EK, Sellers WR, Kaelin WG . Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 1994; 14: 6607\u20136615.","journal-title":"Mol Cell Biol"},{"key":"BFleu201299_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/sj.onc.1210735","volume":"27","author":"MR Campanero","year":"2008","unstructured":"Campanero MR, Herrero A, Calvo V . The histone deacetylase inhibitor trichostatin A induces GADD45 gamma expression via Oct and NF-Y binding sites. Oncogene 2008; 27: 1263\u20131272.","journal-title":"Oncogene"},{"key":"BFleu201299_CR26","doi-asserted-by":"publisher","first-page":"8442","DOI":"10.1128\/MCB.19.12.8442","volume":"19","author":"MR Campanero","year":"1999","unstructured":"Campanero MR, Armstrong M, Flemington E . Distinct cellular factors regulate the c-myb promoter through its E2F element. Mol Cell Biol 1999; 19: 8442\u20138450.","journal-title":"Mol Cell Biol"},{"key":"BFleu201299_CR27","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1002\/eji.1830221219","volume":"22","author":"AG Santis","year":"1992","unstructured":"Santis AG, Campanero MR, Alonso JL, Sanchez-Madrid F . Regulation of tumor necrosis factor (TNF)-alpha synthesis and TNF receptors expression in T lymphocytes through the CD2 activation pathway. Eur J Immunol 1992; 22: 3155\u20133160.","journal-title":"Eur J Immunol"},{"key":"BFleu201299_CR28","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/carcin\/bgp002","volume":"30","author":"J Alvaro-Blanco","year":"2009","unstructured":"Alvaro-Blanco J, Martinez-Gac L, Calonge E, Rodriguez-Martinez M, Molina-Privado I, Redondo JM et al. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence. Carcinogenesis 2009; 30: 440\u2013448.","journal-title":"Carcinogenesis"},{"key":"BFleu201299_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0092-8674(92)90214-W","volume":"68","author":"S Shirodkar","year":"1992","unstructured":"Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T . The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle regulated manner. Cell 1992; 68: 157\u2013166.","journal-title":"Cell"},{"key":"BFleu201299_CR30","doi-asserted-by":"publisher","first-page":"7632","DOI":"10.1038\/sj.onc.1206840","volume":"22","author":"K Araki","year":"2003","unstructured":"Araki K, Nakajima Y, Eto K, Ikeda MA . Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Oncogene 2003; 22: 7632\u20137641.","journal-title":"Oncogene"},{"key":"BFleu201299_CR31","doi-asserted-by":"publisher","first-page":"12406","DOI":"10.1074\/jbc.272.19.12406","volume":"272","author":"S Iwase","year":"1997","unstructured":"Iwase S, Furukawa Y, Kikuchi J, Nagai M, Terui Y, Nakamura M et al. Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells. J Biol Chem 1997; 272: 12406\u201312414.","journal-title":"J Biol Chem"},{"key":"BFleu201299_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ijc.2910190309","volume":"19","author":"K Nilsson","year":"1977","unstructured":"Nilsson K, Giovanella BC, Stehlin JS, Klein G . Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer 1977; 19: 337\u2013344.","journal-title":"Int J Cancer"},{"key":"BFleu201299_CR33","doi-asserted-by":"publisher","first-page":"e1000640","DOI":"10.1371\/journal.pgen.1000640","volume":"5","author":"RE Rempel","year":"2009","unstructured":"Rempel RE, Mori S, Gasparetto M, Glozak MA, Andrechek ER, Adler SB et al. A role for E2F activities in determining the fate of Myc-induced lymphomagenesis. PLoS Genet 2009; 5: e1000640.","journal-title":"PLoS Genet"},{"key":"BFleu201299_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985; 318: 533\u2013538.","journal-title":"Nature"},{"key":"BFleu201299_CR35","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","volume":"192","author":"AL Kovalchuk","year":"2000","unstructured":"Kovalchuk AL, Qi CF, Torrey TA, Taddesse-Heath L, Feigenbaum L, Park SS et al. Burkitt lymphoma in the mouse. J Exp Med 2000; 192: 1183\u20131190.","journal-title":"J Exp Med"},{"key":"BFleu201299_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/hmg\/10.7.699","volume":"10","author":"JR Nevins","year":"2001","unstructured":"Nevins JR . The Rb\/E2F pathway and cancer. Hum Mol Genet 2001; 10: 699\u2013703.","journal-title":"Hum Mol Genet"},{"key":"BFleu201299_CR37","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1093\/nar\/gki855","volume":"33","author":"J Christensen","year":"2005","unstructured":"Christensen J, Cloos P, Toftegaard U, Klinkenberg D, Bracken AP, Trinh E et al. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Nucleic Acids Res 2005; 33: 5458\u20135470.","journal-title":"Nucleic Acids Res"},{"key":"BFleu201299_CR38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s10038-004-0146-3","volume":"49","author":"M Onda","year":"2004","unstructured":"Onda M, Nagai H, Yoshida A, Miyamoto S, Asaka S, Akaishi J et al. Up-regulation of transcriptional factor E2F1 in papillary and anaplastic thyroid cancers. J Hum Genet 2004; 49: 312\u2013318.","journal-title":"J Hum Genet"},{"key":"BFleu201299_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbaexp.2006.02.004","volume":"1759","author":"Y Goto","year":"2006","unstructured":"Goto Y, Hayashi R, Muramatsu T, Ogawa H, Eguchi I, Oshida Y et al. JPO1\/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity. Biochim Biophys Acta 2006; 1759: 60\u201368.","journal-title":"Biochim Biophys Acta"},{"key":"BFleu201299_CR40","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1073\/pnas.92.5.1357","volume":"92","author":"G Xu","year":"1995","unstructured":"Xu G, Livingston DM, Krek W . Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl Acad Sci USA 1995; 92: 1357\u20131361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201299_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrm714","volume":"3","author":"JM Trimarchi","year":"2002","unstructured":"Trimarchi JM, Lees JA . Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3: 11\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFleu201299_CR42","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/sj.onc.1202500","volume":"18","author":"Y Furukawa","year":"1999","unstructured":"Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M . Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4\/pRB and E2F-4\/p130 complexes. Oncogene 1999; 18: 2003\u20132014.","journal-title":"Oncogene"},{"key":"BFleu201299_CR43","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1182\/blood-2010-08-301556","volume":"117","author":"PP Piccaluga","year":"2011","unstructured":"Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C et al. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood 2011; 117: 3596\u20133608.","journal-title":"Blood"},{"key":"BFleu201299_CR44","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1101\/gad.10.23.2960","volume":"10","author":"G Hateboer","year":"1996","unstructured":"Hateboer G, Kerkhoven RM, Shvarts A, Bernards R, Beijersbergen RL . Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev 1996; 10: 2960\u20132970.","journal-title":"Genes Dev"},{"key":"BFleu201299_CR45","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1101\/gad.10.23.2949","volume":"10","author":"F Hofmann","year":"1996","unstructured":"Hofmann F, Martelli F, Livingston DM, Wang Z . The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev 1996; 10: 2949\u20132959.","journal-title":"Genes Dev"},{"key":"BFleu201299_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/8984","volume":"1","author":"A Marti","year":"1999","unstructured":"Marti A, Wirbelauer C, Scheffner M, Krek W . Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1999; 1: 14\u201319.","journal-title":"Nat Cell Biol"},{"key":"BFleu201299_CR47","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1182\/blood-2005-09-008656","volume":"108","author":"KM Kinross","year":"2006","unstructured":"Kinross KM, Clark AJ, Iazzolino RM, Humbert PO . E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation. Blood 2006; 108: 886\u2013895.","journal-title":"Blood"},{"key":"BFleu201299_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/cvr\/cvp383","volume":"86","author":"MJ van Amerongen","year":"2010","unstructured":"van Amerongen MJ, Diehl F, Novoyatleva T, Patra C, Engel FB . E2F4 is required for cardiomyocyte proliferation. Cardiovasc Res 2010; 86: 92\u2013102.","journal-title":"Cardiovasc Res"},{"key":"BFleu201299_CR49","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/jcp.21859","volume":"221","author":"H Garneau","year":"2009","unstructured":"Garneau H, Paquin MC, Carrier JC, Rivard N . E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells. J Cell Physiol 2009; 221: 350\u2013358.","journal-title":"J Cell Physiol"},{"key":"BFleu201299_CR50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12094-008-0193-x","volume":"10","author":"MR Campanero","year":"2008","unstructured":"Campanero MR . Mechanisms involved in Burkitt's tumor formation. Clin Transl Oncol 2008; 10: 250\u2013255.","journal-title":"Clin Transl Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201299","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:11:52Z","timestamp":1648739512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,5]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["BFleu201299"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.99","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,5]]},"assertion":[{"value":"20 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}